Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104447753B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel reductive amination process for sitagliptin intermediates eliminates precious metals, enhancing purity and supply chain reliability for global pharmaceutical manufacturing partners.